BCL2 and cancer: In pancreatic cancer, Bak (Bcl-2 antagonist/killer protein) expression and apoptosis occur in regions of chronic inflammation surrounding the cancer cells but not in the tumor cells themselves, which may simplify accelerated growth and spread [63].